The permitting process for Atlas commenced back in Q3 2021. However, as a result of regulatory departments’ inability
to meet guideline timelines, the permitting process has been delayed by more than a year.
Q1 2024 saw limited progress on Atlas permitting, however significant
progress was made during the June quarter which when finalised is expected to lead to the commencement of
construction at Atlas in Q3 2024 and commencement of commissioning in late Q4 2024 or early Q1 2025
6 months to relocate build and commission wcp...hectic but possible
kcf
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
The permitting process for Atlas commenced back in Q3 2021....
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMA (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.0¢ |
Change
-0.008(8.16%) |
Mkt cap ! $101.0M |
Open | High | Low | Value | Volume |
9.7¢ | 9.7¢ | 9.0¢ | $61.47K | 676.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 164100 | 8.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.7¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 164100 | 0.088 |
4 | 220000 | 0.085 |
1 | 40000 | 0.084 |
1 | 32075 | 0.083 |
4 | 77500 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.097 | 100000 | 1 |
0.098 | 89999 | 2 |
0.100 | 219020 | 4 |
0.105 | 352000 | 3 |
0.110 | 828530 | 7 |
Last trade - 14.53pm 12/11/2024 (20 minute delay) ? |
Featured News
IMA (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online